Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis.
Endometriosis is a disorder in which endometrial tissue is found outside the uterus causing pain, infertility and stress. Finding effective, non-hormonal and long-term treatments for endometriosis still remains one of the most significant challenges in the field. Corticotropin releasing hormone (CRH...
Main Authors: | Annelyn Torres-Reverón, Leslie L Rivera-Lopez, Idhaliz Flores, Caroline B Appleyard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6235236?pdf=render |
Similar Items
-
Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis.
by: Annelyn Torres-Reverón, et al.
Published: (2020-01-01) -
Antalarmin
by: Stephen R. Slauson, et al.
Published: (2008-08-01) -
Metabolomics in endometriosis: challenges and perspectives for future studies
by: Camila N Ortiz, et al.
Published: (2021-05-01) -
Corticotropin-releasing hormone、Corticotropin-releasing hormone receptor、Proopiomelanocortin and Phagocytosis in relation to stress response in grouper (Epinephelus coioides)
by: Fcng-You Lin, et al.
Published: (2005) -
Endocrinology and the brain: corticotropin-releasing hormone signaling
by: Carolina Inda, et al.
Published: (2017-08-01)